Viewing StudyNCT00151242



Ignite Creation Date: 2024-05-05 @ 11:51 AM
Last Modification Date: 2024-10-26 @ 9:14 AM
Study NCT ID: NCT00151242
Status: COMPLETED
Last Update Posted: 2017-09-20
First Post: 2005-09-06

Brief Title: Study on All-Trans Retinoic Acid Induction and Consolidation Therapy and Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia
Sponsor: University of Ulm
Organization: University of Ulm

Organization Data

Organization: University of Ulm
Class: OTHER
Study ID: AMLSG07-04
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: University of Ulm
Lead Sponsor Class: OTHER
Responsible Party: Prof Dr Richard Schlenk
Responsible Party Title: PD Dr
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation: University of Ulm
Old Name: None
Old Organization: None

Collaborators